Coltea Clinical Hospital
About Coltea Clinical Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
5
AOP Orphan Pharmaceuticals AG
2
Celgene
2
EMD Serono Research & Development Institute, Inc.
2
NanoCarrier Co., Ltd.
2
4SC AG
1
Antisoma Research
1
Bayer
1
BeiGene
1
Daiichi Sankyo, Inc.
1
Loxo Oncology, Inc.
1
Clinical Trials at Coltea Clinical Hospital
During the past decade, Coltea Clinical Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery
2007-07-01
2008-08-01
Completed
267
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
2007-06-01
Unknown status
420
Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
2009-03-31
2009-12-31
Completed
204
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
2009-01-27
2020-10-27
Completed
317
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
2009-10-13
2018-05-09
Completed
450
Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma
2009-12-01
2013-03-01
Completed
37
Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
2010-07-14
2017-12-05
Completed
792
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
2011-01-01
2012-05-01
Completed
143
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Coltea Clinical Hospital" #1 sponsor was "Amgen" with 5 trials, followed by "AOP Orphan Pharmaceuticals AG" with 2 trials
sponsored, "Celgene" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "NanoCarrier Co., Ltd."
with 2 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Coltea Clinical Hospital"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator, "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator and "PharmaEssentia Corporation (for the U.S.)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Coltea Clinical Hospital
According to Clinical.Site data, the most researched conditions in "Coltea Clinical Hospital" are
"Polycythemia Vera" (2 trials), "Relapsed Multiple Myeloma" (2 trials), "Abdominal Surgery" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Anaplastic Large-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Coltea Clinical Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Coltea Clinical Hospital
Most popular intervention types in "Coltea Clinical Hospital" are "Drug" (28 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Lenalidomide" (4 trials), "Carfilzomib" (3 trials), "Dexamethasone" (3 trials) and "Avelumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Coltea Clinical Hospital
The vast majority of trials in "Coltea Clinical Hospital" are
29 trials for "All" genders.
Clinical Trials Status at Coltea Clinical Hospital
Currently, there are NaN active trials in "Coltea Clinical Hospital".
undefined are not yet recruiting,
3 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Coltea Clinical Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Coltea Clinical Hospital, 3 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Coltea Clinical Hospital
Coltea Clinical Hospital has several departments that took part in Clinical trials: "Spitalul Clinic Coltea; Clinica de Hematologie" - 7 trials
Departments List
Name
City
Trials